Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle Aspirates
Observational Model: Case-Only, Time Perspective: Prospective
Use of Ribonucleic acid-based molecular signature of tumor samples obtained by fine needle aspirate to discriminate subtypes of tumors relevant to treatment and outcomes.
To test a an 8-gene panel's accuracy in discriminating Non-Small Cell Lung Cancer tumors subtypes that are relevant to treatment and expected outcomes.
Jimmy Ruiz, MD
Wake Forest University
United States: Institutional Review Board
|Wake Forest University Health Sciences||Winston-Salem, North Carolina 27157|